Search

Search bills, members, committees and pages...

JENNIFER WAGNER

5 federal lobbying filings, 2023 to 2024.

JENNIFER WAGNER is a registered lobbyist named on 5 federal lobbying filings, 2023 to 2024.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20244$3.4M
20231$720K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues5
MMMMedicare/Medicaid5
PHAPharmacy5
TARTariff (miscellaneous tariff bills)5
TAXTaxation/Internal Revenue Code5

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 fourth_quarter$560KJan 21, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 third_quarter$640KOct 17, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 second_quarter$650KJul 19, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 first_quarter$1.6MApr 17, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 fourth_quarter$720KJan 21, 2024